... maybe not this time. We have the reputations of well respected lifetime career professionals, Fadrian, Hammond, Kaufmann on our team and the tweet was slanderous, imho to Anavex. The changes in the trial design made it more rigorous to achieve a positive outcome. I would be a little worried, again imho, if I were AF...
News 
Market Data 
Discover 
